News und Analysen
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021
DGAP-Adhoc: Dermapharm Holding SE hebt EBITDA-Prognose für das Gesamtjahr 2021 an
DGAP-Adhoc: Dermapharm Holding SE hebt EBITDA-Prognose für das Gesamtjahr 2021 an
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
DGAP-News: Dermapharm Holding SE übernimmt C³-Gruppe und baut ihre Aktivitäten im Cannabis-Markt aus
DGAP-News: Dermapharm Holding SE übernimmt C³-Gruppe und baut ihre Aktivitäten im Cannabis-Markt aus
DGAP-Adhoc: Dermapharm Holding SE: Übernahme der C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Übernahme der C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH